ADVANCED MALIGNANT TUMOUR
Clinical trials for ADVANCED MALIGNANT TUMOUR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMOUR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMOUR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called HRS-7058 combined with other cancer drugs in 300 adults with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find the best dose and see if the combination is safe and shrinks tumors. Participants must have …
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThis early-stage trial is testing a new drug called HRS-7058 in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study aims to find the safest dose and see if the drug can shrink tumors or slow their growth. About 233 participants will r…
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC